Dr Michael Scott Levy, PHD | |
7 Island Way, Andover, MA 01810-6044 | |
(978) 470-3537 | |
Not Available |
Full Name | Dr Michael Scott Levy |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 43 Years |
Location | 7 Island Way, Andover, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407934060 | NPI | - | NPPES |
0513164 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 3354 (Massachusetts) | Primary |
Entity Name | North Shore Medical Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730121633 PECOS PAC ID: 3274427570 Enrollment ID: O20040405001019 |
News Archive
Qing-Hui Chen's research focuses on hypertension, heart failure and the neuromechanisms that underlie these problems. Specifically, his research examines how a particular ion channel (that regulates resting and action in membranes)—the potassium channel (SK)—is linked to heart disease.
In a recently published study, researchers from the Turku Bioscience Centre at the University of Turku and Åbo Akademi University in Finland monitored the production of new proteins as they were produced by the cells' protein building machinery, the ribosome.
Ascent Therapeutics announced today that the Company has demonstrated efficacy in preclinical models in two Pepducin projects. One of the projects targets CXCR4, a key regulator of stem cell and inflammatory cell homeostasis. A second project has yielded the first potent Pepducin agonists for an undisclosed cardiovascular target.
In a first-of-its kind study, University of Michigan researchers will provide genetic testing and Alzheimer's risk estimates for people who are already experiencing mild cognitive impairment.
› Verified 9 days ago
Entity Name | North Shore Physicians Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588606123 PECOS PAC ID: 3577467224 Enrollment ID: O20050429000668 |
News Archive
Qing-Hui Chen's research focuses on hypertension, heart failure and the neuromechanisms that underlie these problems. Specifically, his research examines how a particular ion channel (that regulates resting and action in membranes)—the potassium channel (SK)—is linked to heart disease.
In a recently published study, researchers from the Turku Bioscience Centre at the University of Turku and Åbo Akademi University in Finland monitored the production of new proteins as they were produced by the cells' protein building machinery, the ribosome.
Ascent Therapeutics announced today that the Company has demonstrated efficacy in preclinical models in two Pepducin projects. One of the projects targets CXCR4, a key regulator of stem cell and inflammatory cell homeostasis. A second project has yielded the first potent Pepducin agonists for an undisclosed cardiovascular target.
In a first-of-its kind study, University of Michigan researchers will provide genetic testing and Alzheimer's risk estimates for people who are already experiencing mild cognitive impairment.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael Scott Levy, PHD 7 Island Way, Andover, MA 01810-6044 Ph: (978) 470-3537 | Dr Michael Scott Levy, PHD 7 Island Way, Andover, MA 01810-6044 Ph: (978) 470-3537 |
News Archive
Qing-Hui Chen's research focuses on hypertension, heart failure and the neuromechanisms that underlie these problems. Specifically, his research examines how a particular ion channel (that regulates resting and action in membranes)—the potassium channel (SK)—is linked to heart disease.
In a recently published study, researchers from the Turku Bioscience Centre at the University of Turku and Åbo Akademi University in Finland monitored the production of new proteins as they were produced by the cells' protein building machinery, the ribosome.
Ascent Therapeutics announced today that the Company has demonstrated efficacy in preclinical models in two Pepducin projects. One of the projects targets CXCR4, a key regulator of stem cell and inflammatory cell homeostasis. A second project has yielded the first potent Pepducin agonists for an undisclosed cardiovascular target.
In a first-of-its kind study, University of Michigan researchers will provide genetic testing and Alzheimer's risk estimates for people who are already experiencing mild cognitive impairment.
› Verified 9 days ago
Dr. John Charles Pakstis, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3 Dundee Park Dr, Suite 203, Andover, MA 01810 Phone: 978-475-3590 | |
Dr. Susan J. Foster, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 14 Highvale Ln, Andover, MA 01810 Phone: 978-475-7300 | |
Dr. Richard Norman Shulik, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 35 Clark Rd, Andover, MA 01810 Phone: 978-764-0592 Fax: 603-437-5588 | |
Dr. Daniel Ralph Morocco, ED.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 10 Main St., Andover, MA 01810 Phone: 978-247-6006 Fax: 978-474-6455 | |
Kathryn R Bradbury, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 26 Chestnut St Ste 2e, Andover, MA 01810 Phone: 978-749-2700 | |
Mr. Gerald M Dugal, EDD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8 Theodore Avenue, Andover, MA 01810 Phone: 978-475-3501 Fax: 978-837-5209 | |
Nancy Cahan, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 10 Essex St, #8, Andover, MA 01810 Phone: 978-474-9336 |